Back to Journals

Pharmacogenomics and Personalized Medicine


ISSN: 1178-7066

Editor-in-Chief: Dr Martin H Bluth

An international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 

Special offer: Original research and review papers submitted by December 31, 2017 using the promotional code PRJ16 will receive a fee waiver off the publication processing fee.  

  

Indexed online:

  • Emerging Sources Citation Index (ESCI), from 2016
  • PubMed and PubMed Central (Pharmgenomics Pers Med
  • Embase, from 2009 (Correct as at December 8, 2016)
  • Scopus, from 2009 (Correct as at December 8, 2016)
  • Directory of Open Access Journals (DOAJ)
  • OAIster: The Open Access Initiative